research
∙
01/24/2023
Oncology clinical trial design planning based on a multistate model that jointly models progression-free and overall survival endpoints
When planning an oncology clinical trial, the usual approach is to assum...
share
research
∙
11/27/2020
Design aspects of COVID-19 treatment trials: Improving probability and time of favourable events
As a reaction to the pandemic of the severe acute respiratory syndrome c...
research
∙
08/18/2020
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY) – estimation of adverse event risks
The SAVVY project aims to improve the analyses of adverse event (AE) dat...
research
∙
08/18/2020
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY) – comparison of adverse event risks in randomized controlled trials
Analyses of adverse events (AEs) are an important aspect of benefit-risk...
research
∙
04/14/2020
Estimating state occupation and transition probabilities in non-Markov multi-state models subject to both random left-truncation and right-censoring
The Aalen-Johansen estimator generalizes the Kaplan-Meier estimator for ...
research
∙
01/16/2020
Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing events
Safety analyses in terms of adverse events (AEs) are an important aspect...
research
∙
11/30/2019
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY): Rationale and statistical concept of a meta-analytic study
The assessment of safety is an important aspect of the evaluation of new...
research
∙
10/25/2018
